{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T22:08:17Z","timestamp":1778364497091,"version":"3.51.4"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T00:00:00Z","timestamp":1386288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11910-013-0423-7","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T05:23:06Z","timestamp":1386220986000},"source":"Crossref","is-referenced-by-count":70,"title":["Recent Advances in Moyamoya Disease: Pathophysiology and Treatment"],"prefix":"10.1007","volume":"14","author":[{"given":"Annick","family":"Kronenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees P. J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"van der Zwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina J. M.","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"423_CR1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337.","journal-title":"N Engl J Med"},{"key":"423_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399.","journal-title":"Arch Neurol"},{"key":"423_CR3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jnnp-2011-301387","volume":"83","author":"R Kleinloog","year":"2012","unstructured":"Kleinloog R, Regli L, Rinkel GJ, Klijn CJ. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. J Neurol Neurosurg Psychiatry. 2012;83:531\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp.2009.181487","volume":"82","author":"HJ Cho","year":"2011","unstructured":"Cho HJ, Jung YH, Kim YD, et al. The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. J Neurol Neurosurg Psychiatry. 2011;82:38\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","volume":"24","author":"Y Takekawa","year":"2004","unstructured":"Takekawa Y, Umezawa T, Ueno Y, Sawada T, Kobayashi M. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology. 2004;24:236\u201342.","journal-title":"Neuropathology"},{"issue":"Suppl 2","key":"423_CR6","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0303-8467(97)00044-9","volume":"99","author":"Y Hosoda","year":"1997","unstructured":"Hosoda Y, Ikeda E, Hirose S. Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease). Clin Neurol Neurosurg. 1997;99 Suppl 2:S203\u20138.","journal-title":"Clin Neurol Neurosurg"},{"key":"423_CR7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00701-012-1472-4","volume":"154","author":"Y Kaku","year":"2012","unstructured":"Kaku Y, Morioka M, Ohmori Y, et al. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien). 2012;154:2151\u20137.","journal-title":"Acta Neurochir (Wien)"},{"key":"423_CR8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/WNL.0b013e3182825162","volume":"80","author":"JM Kim","year":"2013","unstructured":"Kim JM, Jung KH, Sohn CH, et al. High-resolution MR technique can distinguish moyamoya disease from atherosclerotic occlusion. Neurology. 2013;80:775\u20136.","journal-title":"Neurology"},{"key":"423_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3171\/jns.1983.58.1.0120","volume":"58","author":"M Yamashita","year":"1983","unstructured":"Yamashita M, Tanaka K, Matsuo T, et al. Cerebral dissecting aneurysms in patients with moyamoya disease. Report of two cases. J Neurosurg. 1983;58:120\u20135.","journal-title":"J Neurosurg"},{"key":"423_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2176\/nmc.52.267","volume":"52","author":"K Houkin","year":"2012","unstructured":"Houkin K, Ito M, Sugiyama T, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo). 2012;52:267\u201377.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"423_CR11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3171\/2013.1.JNS12565","volume":"118","author":"T Jiang","year":"2013","unstructured":"Jiang T, Perry A, Dacey Jr RG, Zipfel GJ, Derdeyn CP. Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings. J Neurosurg. 2013;118:1030\u20134.","journal-title":"J Neurosurg"},{"key":"423_CR12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jnnp.2006.096040","volume":"77","author":"Y Mineharu","year":"2006","unstructured":"Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77:1025\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1468-1331.2011.03536.x","volume":"19","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Heinemann FM, Horn PA, et al. Inheritance of moyamoya disease in a Caucasian family. Eur J Neurol. 2012;19:438\u201342.","journal-title":"Eur J Neurol"},{"key":"423_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0b013e3181e8ee3f","volume":"75","author":"D Herve","year":"2010","unstructured":"Herve D, Touraine P, Verloes A, et al. A hereditary moyamoya syndrome with multisystemic manifestations. Neurology. 2010;75:259\u201364.","journal-title":"Neurology"},{"key":"423_CR16","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/brain\/aws172","volume":"135","author":"P Munot","year":"2012","unstructured":"\u2022 Munot P, Saunders DE, Milewicz DM, et al. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain. 2012;135:2506\u201314. This article describes the distinctive angiographic features of the intracranial vasculopathy associated with ACTA2 mutations.","journal-title":"Brain"},{"key":"423_CR17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhg.2010.103","volume":"55","author":"C Roder","year":"2010","unstructured":"Roder C, Nayak NR, Khan N, et al. Genetics of moyamoya disease. J Hum Genet. 2010;55:711\u20136.","journal-title":"J Hum Genet"},{"key":"423_CR18","doi-asserted-by":"crossref","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"\u2022\u2022 Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542. This study (as well as [19]) has identified RNF213 as the first MMD gene.","journal-title":"PLoS One"},{"key":"423_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"\u2022\u2022 Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56:34\u201340. This study (as well as [18]) has identified RNF213 as the first MMD gene.","journal-title":"J Hum Genet"},{"key":"423_CR20","doi-asserted-by":"crossref","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Jiang H, Zhang L, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One. 2012;7:e48179.","journal-title":"PLoS One"},{"key":"423_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2176\/nmc.52.299","volume":"52","author":"W Liu","year":"2012","unstructured":"Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo). 2012;52:299\u2013303.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"423_CR22","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1161\/STROKEAHA.112.663864","volume":"43","author":"S Miyawaki","year":"2012","unstructured":"Miyawaki S, Imai H, Takayanagi S, et al. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis\/occlusion. Stroke. 2012;43:3371\u20134.","journal-title":"Stroke"},{"issue":"1","key":"423_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, et al. Downregulation of securin by the variant RNF213 R4810K reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun. 2013;438(1):13\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"423_CR24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576G\u2009>\u2009A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78:803\u201310.","journal-title":"Neurology"},{"key":"423_CR25","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2009.1.FOCUS08302","volume":"26","author":"AS Achrol","year":"2009","unstructured":"Achrol AS, Guzman R, Lee M, Steinberg GK. Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus. 2009;26:E4.","journal-title":"Neurosurg Focus"},{"key":"423_CR26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2176\/nmc.52.267","volume":"52","author":"K Houkin","year":"2012","unstructured":"Houkin K, Ito M, Sugiyama T, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo). 2012;52:267\u201377.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"423_CR27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","volume":"9","author":"JE Rundhaug","year":"2005","unstructured":"Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9:267\u201385.","journal-title":"J Cell Mol Med"},{"key":"423_CR29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T. Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol. 2009;72:476\u201380. discussion 480.","journal-title":"Surg Neurol"},{"key":"423_CR30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jnr.22228","volume":"88","author":"JH Kim","year":"2010","unstructured":"Kim JH, Jung JH, Phi JH, et al. Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res. 2010;88:510\u20138.","journal-title":"J Neurosci Res"},{"key":"423_CR31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/jcbfm.2008.67","volume":"28","author":"KH Jung","year":"2008","unstructured":"Jung KH, Chu K, Lee ST, et al. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease. J Cereb Blood Flow Metab. 2008;28:1795\u2013803.","journal-title":"J Cereb Blood Flow Metab"},{"key":"423_CR33","first-page":"74","volume":"24","author":"D Zou","year":"2011","unstructured":"Zou D, Zhao J, Zhang D, et al. Enhancement expression of bFGF in Chinese patients with moyamoya disease. Biomed Environ Sci. 2011;24:74\u201380.","journal-title":"Biomed Environ Sci"},{"key":"423_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3340\/jkns.2010.48.1.8","volume":"48","author":"EJ Koh","year":"2010","unstructured":"Koh EJ, Kim HN, Ma TZ, Choi HY, Kwak YG. Comparative analysis of serum proteomes of moyamoya disease and normal controls. J Korean Neurosurg Soc. 2010;48:8\u201313.","journal-title":"J Korean Neurosurg Soc"},{"key":"423_CR35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2377-10-112","volume":"10","author":"Y Araki","year":"2010","unstructured":"Araki Y, Yoshikawa K, Okamoto S, et al. Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS. BMC Neurol. 2010;10:112.","journal-title":"BMC Neurol"},{"key":"423_CR36","doi-asserted-by":"crossref","first-page":"e36386","DOI":"10.1371\/journal.pone.0036386","volume":"7","author":"R Lin","year":"2012","unstructured":"\u2022 Lin R, Xie Z, Zhang J, et al. Clinical and immunopathological features of moyamoya disease. PLoS One. 2012;7:e36386. This study reports the immunological results from a large group of MMD patients (n\u2009=\u200965), including the histopathological features of three patients.","journal-title":"PLoS One"},{"key":"423_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1172-8-45","volume":"8","author":"TK Sigdel","year":"2013","unstructured":"\u2022 Sigdel TK, Shoemaker LD, Chen R, et al. Immune response profiling identifies autoantibodies specific to moyamoya patients. Orphanet J Rare Dis. 2013;8:45. This is the first study to provide high-throughput analysis of autoantibodies in MMD.","journal-title":"Orphanet J Rare Dis."},{"key":"423_CR38","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","volume":"44","author":"RS Bower","year":"2013","unstructured":"Bower RS, Mallory GW, Nwojo M, et al. Moyamoya disease in a primarily white, Midwestern US population: increased prevalence of autoimmune disease. Stroke. 2013;44:1997\u20139.","journal-title":"Stroke"},{"key":"423_CR39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/STROKEAHA.110.608471","volume":"42","author":"H Li","year":"2011","unstructured":"Li H, Zhang ZS, Dong ZN, et al. Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study. Stroke. 2011;42:1138\u20139.","journal-title":"Stroke"},{"key":"423_CR40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/STROKEAHA.109.562264","volume":"41","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Heo KG, Shin HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke. 2010;41:173\u20136.","journal-title":"Stroke"},{"key":"423_CR41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","volume":"19","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Berlit P, Diesner F, Khan N. What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide survey. Eur J Neurol. 2012;19:163\u20137.","journal-title":"Eur J Neurol"},{"key":"423_CR42","doi-asserted-by":"crossref","unstructured":"\u2022 Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245\u201366. This article extensively reports the evidence-based guidelines for the diagnosis and treatment of MMV.","DOI":"10.2176\/nmc.52.245"},{"key":"423_CR43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11940-012-0195-4","volume":"14","author":"ER Smith","year":"2012","unstructured":"Smith ER. Moyamoya arteriopathy. Curr Treat Options Neurol. 2012;14:549\u201356.","journal-title":"Curr Treat Options Neurol"},{"key":"423_CR44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-8749.2009.03527.x","volume":"52","author":"V Ganesan","year":"2010","unstructured":"Ganesan V. Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist's perspective. Dev Med Child Neurol. 2010;52:10\u20133.","journal-title":"Dev Med Child Neurol"},{"key":"423_CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000320253","volume":"31","author":"N Khan","year":"2011","unstructured":"Khan N, Dodd R, Marks MP, et al. Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in moyamoya angiopathy. Cerebrovasc Dis. 2011;31:147\u201353.","journal-title":"Cerebrovasc Dis"},{"key":"423_CR46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/2011.12.PEDS1172","volume":"9","author":"ER Smith","year":"2012","unstructured":"\u2022 Smith ER, Scott RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. J Neurosurg Pediatr. 2012;9:353\u201360. This article offers practical guidelines with specific evidence-based guidelines for (surgical) treatment.","journal-title":"J Neurosurg Pediatr"},{"key":"423_CR47","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","volume":"39","author":"ES Roach","year":"2008","unstructured":"Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39:2644\u201391.","journal-title":"Stroke"},{"key":"423_CR48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00381-004-1118-9","volume":"21","author":"LW Fung","year":"2005","unstructured":"Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358\u201364.","journal-title":"Childs Nerv Syst"},{"key":"423_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jocn.2012.08.002","volume":"20","author":"BA Gross","year":"2013","unstructured":"Gross BA, Du R. The natural history of moyamoya in a North American adult cohort. J Clin Neurosci. 2013;20:44\u20138.","journal-title":"J Clin Neurosci"},{"key":"423_CR50","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/01.STR.0000182256.32489.99","volume":"36","author":"S Kuroda","year":"2005","unstructured":"Kuroda S, Ishikawa T, Houkin K, et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005;36:2148\u201353.","journal-title":"Stroke"},{"issue":"3","key":"423_CR51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1227\/NEU.0000000000000017","volume":"73","author":"AA Abla","year":"2013","unstructured":"Abla AA, Gandhoke G, Clark JC, et al. Surgical outcomes for moyamoya angiopathy at Barrow Neurological Institute with comparison of adult indirect EDAS bypass, adult direct STA-MCA bypass and pediatric bypass: 154 revascularization surgeries in 140 affected hemispheres. Neurosurgery. 2013;73(3):430\u20139.","journal-title":"Neurosurgery"},{"key":"423_CR52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3171\/2009.4.JNS081649","volume":"111","author":"R Guzman","year":"2009","unstructured":"Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 2009;111:927\u201335.","journal-title":"J Neurosurg"},{"key":"423_CR53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000343225","volume":"34","author":"XY Bao","year":"2012","unstructured":"Bao XY, Duan L, Li DS, et al. Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in China. Cerebrovasc Dis. 2012;34:305\u201313.","journal-title":"Cerebrovasc Dis"},{"key":"423_CR54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1227\/NEU.0b013e3181fc5ec2","volume":"68","author":"JR Dusick","year":"2011","unstructured":"Dusick JR, Gonzalez NR, Martin NA. Clinical and angiographic outcomes from indirect revascularization surgery for moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery. 2011;68:34\u201343. discussion 43.","journal-title":"Neurosurgery"},{"key":"423_CR55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","volume":"43","author":"L Duan","year":"2012","unstructured":"Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012;43:56\u201360.","journal-title":"Stroke"},{"key":"423_CR56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3171\/2012.8.PEDS11539","volume":"10","author":"M Mukawa","year":"2012","unstructured":"Mukawa M, Nariai T, Matsushima Y, et al. Long-term follow-up of surgically treated juvenile patients with moyamoya disease. J Neurosurg Pediatr. 2012;10:451\u20136.","journal-title":"J Neurosurg Pediatr"},{"key":"423_CR57","author":"M Kawabori","year":"2012","unstructured":"Kawabori M, Kuroda S, Nakayama N, et al. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric moyamoya disease. World Neurosurg. 2012. doi: 10.1016\/j.wneu.2012.08.005 .","journal-title":"World Neurosurg."},{"key":"423_CR58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/2011.11.JNS11944","volume":"116","author":"Y Okada","year":"2012","unstructured":"Okada Y, Kawamata T, Kawashima A, et al. The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg. 2012;116:672\u20139.","journal-title":"J Neurosurg"},{"key":"423_CR59","author":"K Chao","year":"2012","unstructured":"Chao K, Steinberg GK. Re: \"Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric moyamoya disease\". World Neurosurg. 2012. doi: 10.1016\/j.wneu.2012.11.018 .","journal-title":"World Neurosurg."},{"key":"423_CR60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2176\/nmc.44.218","volume":"44","author":"S Miyamoto","year":"2004","unstructured":"Miyamoto S, Japan Adult Moyamoya Trial Group. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset\u2014the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo). 2004;44:218\u20139.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"423_CR61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jnnp-2012-302236","volume":"84","author":"X Liu","year":"2013","unstructured":"Liu X, Zhang D, Shuo W, et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry. 2013;84:258\u201365.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2152-7806.97730","volume":"3","author":"RW Ryan","year":"2012","unstructured":"Ryan RW, Chowdhary A, Britz GW. Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in moyamoya disease: a review of the literature. Surg Neurol Int. 2012;3:72.","journal-title":"Surg Neurol Int."},{"key":"423_CR63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000321901","volume":"31","author":"JY Lee","year":"2011","unstructured":"Lee JY, Phi JH, Wang KC, et al. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovasc Dis. 2011;31:230\u20137.","journal-title":"Cerebrovasc Dis"},{"key":"423_CR64","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1227\/NEU.0b013e3182320d1a","volume":"70","author":"P Karzmark","year":"2012","unstructured":"Karzmark P, Zeifert PD, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery. 2012;70:634\u20138.","journal-title":"Neurosurgery"},{"key":"423_CR65","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.3171\/2011.3.FOCUS1150","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Rahme RJ, Aoun SG, Batjer HH, Bendok BR. Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurg Focus. 2011;30:E21.","journal-title":"Neurosurg Focus"},{"key":"423_CR66","author":"A Nakamizo","year":"2013","unstructured":"Nakamizo A, Kikkawa Y, Hiwatashi A, Matsushima T, Sasaki T. Executive function and diffusion in frontal white matter of adults with moyamoya disease. J Stroke Cerebrovasc Dis. 2013. doi: 10.1016\/j.jstrokecerebrovasdis.2013.03.022 .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"423_CR67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jnnp-2011-301388","volume":"83","author":"L Calviere","year":"2012","unstructured":"Calviere L, Ssi Yan Kai G, Catalaa I, et al. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter. J Neurol Neurosurg Psychiatry. 2012;83:591\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"423_CR68","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00701-003-0148-5","volume":"145","author":"N Khan","year":"2003","unstructured":"Khan N, Schuknecht B, Boltshauser E, et al. Moyamoya disease and moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien). 2003;145:1061\u201371. discussion 1071.","journal-title":"Acta Neurochir (Wien)"},{"key":"423_CR69","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2009.1.FOCUS08300","volume":"26","author":"M Lee","year":"2009","unstructured":"Lee M, Zaharchuk G, Guzman R, et al. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus. 2009;26:E5.","journal-title":"Neurosurg Focus"},{"key":"423_CR70","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/STROKEAHA.110.603225","volume":"42","author":"JS Han","year":"2011","unstructured":"Han JS, Mikulis DJ, Mardimae A, et al. Measurement of cerebrovascular reactivity in pediatric patients with cerebral vasculopathy using blood oxygen level-dependent MRI. Stroke. 2011;42:1261\u20139.","journal-title":"Stroke"},{"key":"423_CR71","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/STROKEAHA.111.616466","volume":"42","author":"G Zaharchuk","year":"2011","unstructured":"Zaharchuk G, Do HM, Marks MP, et al. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke. 2011;42:2485\u201391.","journal-title":"Stroke"},{"key":"423_CR72","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1016\/j.ejrad.2011.01.016","volume":"80","author":"T Noguchi","year":"2011","unstructured":"Noguchi T, Kawashima M, Irie H, et al. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. Eur J Radiol. 2011;80:e557\u201362.","journal-title":"Eur J Radiol"},{"key":"423_CR73","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3174\/ajnr.A1229","volume":"29","author":"NJ Rim","year":"2008","unstructured":"Rim NJ, Kim HS, Shin YS. Kim SY Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in moyamoya patients. AJNR Am J Neuroradiol. 2008;29:1658\u201363.","journal-title":"AJNR Am J Neuroradiol"},{"key":"423_CR74","doi-asserted-by":"crossref","first-page":"e57595","DOI":"10.1371\/journal.pone.0057595","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wang J, Geng D, et al. Whole-brain CT perfusion and CT angiography assessment of moyamoya disease before and after surgical revascularization: preliminary study with 256-slice CT. PLoS One. 2013;8:e57595.","journal-title":"PLoS One"},{"key":"423_CR75","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nec.2010.03.013","volume":"21","author":"R Guzman","year":"2010","unstructured":"Guzman R, Steinberg GK. Direct bypass techniques for the treatment of pediatric moyamoya disease. Neurosurg Clin N Am. 2010;21:565\u201373.","journal-title":"Neurosurg Clin N Am"},{"key":"423_CR76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-211-76589-0_23","volume":"103","author":"N Khan","year":"2008","unstructured":"Khan N, Yonekawa Y. Moyamoya angiopathy in Europe: the beginnings in Z\u00fcrich, practical lessons learned, increasing awareness and future perspectives. Acta Neurochir Suppl. 2008;103:127\u201330.","journal-title":"Acta Neurochir Suppl"},{"key":"423_CR77","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nec.2010.03.008","volume":"21","author":"NN Patel","year":"2010","unstructured":"Patel NN, Mangano FT, Klimo Jr P. Indirect revascularization techniques for treating moyamoya disease. Neurosurg Clin N Am. 2010;21:553\u201363.","journal-title":"Neurosurg Clin N Am"},{"key":"423_CR78","author":"N McLaughlin","year":"2013","unstructured":"McLaughlin N, Martin NA. Effectiveness of burr holes for indirect revascularization in patients with moyamoya disease\u2014a review of the literature. World Neurosurg. 2013. doi: 10.1016\/j.wneu.2013.05.010 .","journal-title":"World Neurosurg."},{"key":"423_CR79","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1249069","volume":"40","author":"RS Oliveira","year":"2009","unstructured":"Oliveira RS, Amato MC, Simao GN, et al. Effect of multiple cranial burr hole surgery on prevention of recurrent ischemic attacks in children with moyamoya disease. Neuropediatrics. 2009;40:260\u20134.","journal-title":"Neuropediatrics"},{"key":"423_CR80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2176\/nmc.52.333","volume":"52","author":"DS Kim","year":"2012","unstructured":"Kim DS, Huh PW, Kim HS, et al. Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir (Tokyo). 2012;52:333\u20138.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"423_CR81","doi-asserted-by":"crossref","first-page":"E195","DOI":"10.1227\/01.NEU.0000336311.60660.26","volume":"64","author":"T Hayashi","year":"2009","unstructured":"Hayashi T, Shirane R, Tominaga T. Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure: technical case report. Neurosurgery. 2009;64:E195\u20136. discussion E196.","journal-title":"Neurosurgery"},{"key":"423_CR82","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00701-011-1222-z","volume":"154","author":"T Horiuchi","year":"2012","unstructured":"Horiuchi T, Kusano Y, Asanuma M, Hongo K. Posterior auricular artery-middle cerebral artery bypass for additional surgery of moyamoya disease. Acta Neurochir (Wien). 2012;154:455\u20136.","journal-title":"Acta Neurochir (Wien)"},{"key":"423_CR83","doi-asserted-by":"crossref","first-page":"ons145","DOI":"10.1227\/01.NEU.0000382975.86267.40","volume":"67","author":"A Kawashima","year":"2010","unstructured":"Kawashima A, Kawamata T, Yamaguchi K, Hori T, Okada Y. Successful superficial temporal artery-anterior cerebral artery direct bypass using a long graft for moyamoya disease: technical note. Neurosurgery. 2010;67:ons145\u20139. discussion ons149.","journal-title":"Neurosurgery"},{"key":"423_CR84","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1227\/01.NEU.0000369606.00861.91","volume":"66","author":"S Kuroda","year":"2010","unstructured":"Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 2010;66:1093\u2013101. discussion 1101.","journal-title":"Neurosurgery"},{"key":"423_CR85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3171\/2012.9.JNS112354","volume":"118","author":"N McLaughlin","year":"2013","unstructured":"McLaughlin N, Martin NA. Meningeal management for optimal revascularization from middle meningeal artery. J Neurosurg. 2013;118:104\u20138.","journal-title":"J Neurosurg"},{"key":"423_CR86","doi-asserted-by":"crossref","unstructured":"Kronenburg A, Esposito G, Fierstra J, Braun K, Regli L. Combined bypass technique for contemporary revascularization of unilateral MCA and bilateral frontal territories in moyamoya vasculopathy. Acta Neurochir Suppl. 2014;119, in press.","DOI":"10.1007\/978-3-319-02411-0_11"},{"key":"423_CR87","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00381-009-0850-6","volume":"25","author":"J Muto","year":"2009","unstructured":"Muto J, Oi S. Intradural arteriosynangiosis in pediatric moyamoya disease: modified technique of encephalo-duro-arterio-synangiosis with reduced operative damage to already growing revascularization. Childs Nerv Syst. 2009;25:607\u201312.","journal-title":"Childs Nerv Syst"},{"key":"423_CR88","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1161\/STROKEAHA.110.598565","volume":"42","author":"P Pandey","year":"2011","unstructured":"Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42:3304\u201310.","journal-title":"Stroke"},{"key":"423_CR89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/02688697.2012.757294","volume":"27","author":"WG Zhao","year":"2013","unstructured":"Zhao WG, Luo Q, Jia JB, Yu JL. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease. Br J Neurosurg. 2013;27:321\u20135.","journal-title":"Br J Neurosurg"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0423-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-013-0423-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0423-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:57:57Z","timestamp":1716245877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-013-0423-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1007\/s11910-013-0423-7","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,6]]},"article-number":"423"}}